NAPAGE: NAb-PAclitaxel and GEmcitabine in Advanced Soft Tissue Sarcoma

NCT03524898 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
39
Enrollment
OTHER
Sponsor class

Stopped As Last patient last visit (LPLV) took place on 15/02/2022, the trial was ended prematurely on this date in accordance with SAKK/CI.

Conditions

Interventions

Sponsor

Swiss Cancer Institute